null
ChEBI ID: 38809
Member | Definition | Class |
---|---|---|
flubendiamide | flubendiamide |
Timeframe | Studies, Drugs with This Role(%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (10.31) | 29.6817 |
2010's | 66 (68.04) | 24.3611 |
2020's | 21 (21.65) | 2.80 |
Publication Type | Studies, Drugs with this Role (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (2.02%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 97 (97.98%) | 84.16% |
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
---|---|---|---|---|---|
AR protein | Homo sapiens (human) | Potency | 13.1333 | 2 | 2 |
Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 48.8493 | 1 | 1 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 19.1602 | 2 | 2 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 34.4813 | 6 | 6 |
farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 36.9535 | 1 | 1 |
GLI family zinc finger 3 | Homo sapiens (human) | Potency | 6.1065 | 3 | 3 |
heat shock protein beta-1 | Homo sapiens (human) | Potency | 43.9193 | 2 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 38.8023 | 2 | 2 |
nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 10.9360 | 1 | 1 |
peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 40.6745 | 1 | 1 |
pregnane X nuclear receptor | Homo sapiens (human) | Potency | 13.7676 | 1 | 1 |
RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 41.9538 | 2 | 2 |
thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 16.5752 | 3 | 3 |
v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 34.8863 | 1 | 1 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 41.5312 | 2 | 2 |